Sequel Med Tech’s twiist Recognized for Diabetes Management Innovation

Sequel Med Tech’s twiist Automated Insulin Delivery System has won the ‘Best New Technology Solution for Diabetes Management’ at the 2026 MedTech Breakthrough Awards. The system is designed to empower the type 1 diabetes community with personalized insulin delivery, utilizing a unique algorithm that adjusts based on continuous glucose monitor readings. The twiist system features advanced occlusion detection technology and customizable glucose targets, offering flexibility for users. It is compatible with several glucose monitors and aims to enhance the daily management of diabetes for those affected.